Md. stem cell firm’s new product aims to speed medicine development

RoosterBio Inc. has launched a new product that it says could allow for faster and less costly development of regenerative medicine.

To purchase a reprint of this article, contact reprints@thedailyrecord.com.

Leave a Reply

Your email address will not be published. Required fields are marked *